Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05573425

Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars

Comparing the Efficacy of Topical Tazarotene Gel 0.1% Versus Microneedling in Atrophic Post Acne Scars

Sponsor: Jinnah Postgraduate Medical Centre

Conditions Acne Scar

Interventions Microneedling Tazarotene gel 0.1%

Updated 3 times since 2022 Last updated: Oct 11, 2022 Started: Aug 22, 2020 Primary completion: Feb 21, 2021 Completion: Feb 21, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Acne Scar, this trial is completed. The trial is conducted by Jinnah Postgraduate Medical Centre and has accumulated 3 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Nov 2022 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jinnah Postgraduate Medical Centre

Data source: Jinnah Postgraduate Medical Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan